ALDX
Price
$5.05
Change
+$0.16 (+3.27%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
299.53M
42 days until earnings call
BBIO
Price
$35.84
Change
-$0.24 (-0.67%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
6.77B
28 days until earnings call
Ad is loading...

ALDX vs BBIO

Header iconALDX vs BBIO Comparison
Open Charts ALDX vs BBIOBanner chart's image
Aldeyra Therapeutics
Price$5.05
Change+$0.16 (+3.27%)
Volume$2.48K
Capitalization299.53M
BridgeBio Pharma
Price$35.84
Change-$0.24 (-0.67%)
Volume$48.73K
Capitalization6.77B
ALDX vs BBIO Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. BBIO commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and BBIO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (ALDX: $5.03 vs. BBIO: $35.84)
Brand notoriety: ALDX and BBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 68% vs. BBIO: 70%
Market capitalization -- ALDX: $299.53M vs. BBIO: $6.77B
ALDX [@Biotechnology] is valued at $299.53M. BBIO’s [@Biotechnology] market capitalization is $6.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileBBIO’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • BBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and BBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 5 TA indicator(s) are bullish while BBIO’s TA Score has 3 bullish TA indicator(s).

  • ALDX’s TA Score: 5 bullish, 3 bearish.
  • BBIO’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, ALDX is a better buy in the short-term than BBIO.

Price Growth

ALDX (@Biotechnology) experienced а +0.10% price change this week, while BBIO (@Biotechnology) price change was +2.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

ALDX is expected to report earnings on May 01, 2025.

BBIO is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($6.77B) has a higher market cap than ALDX($300M). BBIO YTD gains are higher at: 30.612 vs. ALDX (0.802). ALDX has higher annual earnings (EBITDA): -42.57M vs. BBIO (-350.26M). BBIO has more cash in the bank: 266M vs. ALDX (113M). ALDX has less debt than BBIO: ALDX (15.6M) vs BBIO (1.73B). BBIO has higher revenues than ALDX: BBIO (218M) vs ALDX (0).
ALDXBBIOALDX / BBIO
Capitalization300M6.77B4%
EBITDA-42.57M-350.26M12%
Gain YTD0.80230.6123%
P/E RatioN/AN/A-
Revenue0218M-
Total Cash113M266M42%
Total Debt15.6M1.73B1%
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXBBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
82%
Bearish Trend 16 days ago
79%
Momentum
ODDS (%)
Bullish Trend 16 days ago
88%
Bullish Trend 16 days ago
82%
MACD
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 16 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 16 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 16 days ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
Bearish Trend 25 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 16 days ago
82%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMKBX20.860.07
+0.34%
Morgan Stanley Inst Emerging Mkts A
GLCGX31.35N/A
N/A
Goldman Sachs Large Cap Gr Insghts A
GEMLX12.00N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn C
JGRUX86.33-0.38
-0.44%
JPMorgan US Value R4
ASCRX15.52-0.10
-0.64%
American Century Small Company R

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+2.86%
CANF - ALDX
46%
Loosely correlated
-2.53%
FOLD - ALDX
44%
Loosely correlated
+0.32%
ATAI - ALDX
43%
Loosely correlated
+1.33%
ABSI - ALDX
42%
Loosely correlated
+25.16%
BBIO - ALDX
42%
Loosely correlated
-0.67%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-0.67%
ARGX - BBIO
46%
Loosely correlated
-1.17%
BPMC - BBIO
45%
Loosely correlated
-0.79%
AXON - BBIO
44%
Loosely correlated
+0.33%
ARRY - BBIO
43%
Loosely correlated
-6.38%
PMN - BBIO
43%
Loosely correlated
-5.62%
More